Read More Pharma Industry News Seattle Genetics’ Adcetris receives FDA approval for peripheral T-cell lymphoma Seattle Genetics’ Adcetris, in combination with CHP chemotherapy, gains FDA approval for treating certain types of peripheral T-cell… bypharmanewsdailyNovember 18, 2018
